Ghent University Academic Bibliography

Advanced

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age

Ego Seeman, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman UGent and Jean-Yves Reginster (2010) BONE. 46(4). p.1038-1042
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
BONE-MINERAL DENSITY, RANDOMIZED CLINICAL-TRIAL, LONG-TERM COMPLICATION, POSTMENOPAUSAL OSTEOPOROSIS, BISPHOSPHONATE TREATMENT, HIP FRACTURE, ALENDRONATE THERAPY, ANTIRESORPTIVE AGENTS, COST-EFFECTIVENESS, Clinical trial, ZOLEDRONIC ACID, Strontium Ranelate, Elderly population, Antiosteoporotic treatment, Osteoporosis, Osteoporotic fracture
journal title
BONE
Bone
volume
46
issue
4
pages
1038 - 1042
Web of Science type
Article
Web of Science id
000276009400024
JCR category
ENDOCRINOLOGY & METABOLISM
JCR impact factor
4.601 (2010)
JCR rank
26/115 (2010)
JCR quartile
1 (2010)
ISSN
8756-3282
DOI
10.1016/j.bone.2009.12.006
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1194250
handle
http://hdl.handle.net/1854/LU-1194250
date created
2011-03-22 14:26:53
date last changed
2016-12-19 15:45:50
@article{1194250,
  author       = {Seeman, Ego and Boonen, Steven and Borgstrom, Frederik and Vellas, Bruno and Aquino, Jean-Pierre and Semler, Jutta and Benhamou, Claude-Laurent and Kaufman, Jean and Reginster, Jean-Yves},
  issn         = {8756-3282},
  journal      = {BONE},
  keyword      = {BONE-MINERAL DENSITY,RANDOMIZED CLINICAL-TRIAL,LONG-TERM COMPLICATION,POSTMENOPAUSAL OSTEOPOROSIS,BISPHOSPHONATE TREATMENT,HIP FRACTURE,ALENDRONATE THERAPY,ANTIRESORPTIVE AGENTS,COST-EFFECTIVENESS,Clinical trial,ZOLEDRONIC ACID,Strontium Ranelate,Elderly population,Antiosteoporotic treatment,Osteoporosis,Osteoporotic fracture},
  language     = {eng},
  number       = {4},
  pages        = {1038--1042},
  title        = {Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age},
  url          = {http://dx.doi.org/10.1016/j.bone.2009.12.006},
  volume       = {46},
  year         = {2010},
}

Chicago
Seeman, Ego, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman, and Jean-Yves Reginster. 2010. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-years in Women over 80 Years of Age.” Bone 46 (4): 1038–1042.
APA
Seeman, E., Boonen, S., Borgstrom, F., Vellas, B., Aquino, J.-P., Semler, J., Benhamou, C.-L., et al. (2010). Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE, 46(4), 1038–1042.
Vancouver
1.
Seeman E, Boonen S, Borgstrom F, Vellas B, Aquino J-P, Semler J, et al. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE. 2010;46(4):1038–42.
MLA
Seeman, Ego, Steven Boonen, Frederik Borgstrom, et al. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-years in Women over 80 Years of Age.” BONE 46.4 (2010): 1038–1042. Print.